Accueil > Actualité
Actualite financiere : Actualite bourse

Carmat: EuroLand Corporate initiates buy coverage

( - EuroLand Corporate initiates coverage of Carmat with a 'buy' recommendation and a price target of 6.
8 euros, highlighting the ability of the designer of the Aeson artificial heart to 'revolutionize the heart failure market'.

'With over 60 implants to its credit, and studies showing highly satisfactory results, the company has undeniable assets to establish itself in the sector', believes the analyst in charge of the dossier.

Given the company's progress, the lack of alternatives in the field of total artificial hearts, and the sector's colossal needs, we feel the company is clearly undervalued, with an upside of +215%", he continues.

Copyright (c) 2024 All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.